Guidelines for the clinical management of atrial fibrillation: a practical perspective

Guidelines for the clinical management of atrial fibrillation: a practical perspective

Bibliographic Details
Main Authors:	E Blanc, A Junod
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2004-05-01
Series:	Swiss Medical Weekly
Subjects:	Cardioversion Antiarrhythmic agents anticoagulation Guidelines atrial fibrillation
Online Access:	https://www.smw.ch/index.php/smw/article/view/367

Similar Items

How to Optimize Cardioversion of Atrial Fibrillation
by: K. E. Juhani Airaksinen
Published: (2022-06-01)

Incidence and Determinants of Spontaneous Cardioversion of Early Onset Symptomatic Atrial Fibrillation
by: Marco Valerio Mariani, et al.
Published: (2022-10-01)

Pharmacological Cardioversion after Pre-Treatment with Antiarrythmic Drugs Prior to Electrical Cardioversion in Persistent Atrial Fibrillation: Impact on Maintenance of Sinus Rhythm
by: Amine El Amrani, et al.
Published: (2021-03-01)

Strategy and tactics of emergency treatment of atrial fibrillation: a modern approach to the problem
by: Yu. A Bunin
Published: (2015-03-01)

2020 Clinical guidelines for Atrial fibrillation and atrial flutter
by: M. G. Arakelyan, et al.
Published: (2021-08-01)

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
by: B. A. Tatarskii
Published: (2015-12-01)

Pharmacologic Therapy in the Elderly with Atrial Fibrillation
by: Shih-Huang Lee, et al.
Published: (2008-03-01)

Pharmacological Treatment for Atrial Fibrillation
by: Kaoru Sugi, MD PhD, et al.
Published: (2005-01-01)

Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter
by: E B Maĭkov, et al.
Published: (2015-01-01)

The Challenge of Managing Atrial Fibrillation during Pregnancy
by: Fabiana Lucà, et al.
Published: (2023-10-01)

Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter
by: Amgad Mentias, et al.
Published: (2021-09-01)

THE IMPORTANCE OF EARLY CARDIOVERSION OF PAROXYSMAL ATRIAL FIBRILLATION
by: Franc Verovnik
Published: (2002-01-01)

The efficacy of synchronized direct current shock in reverting long standing persistent atrial fibrillation in to sinus rhythm. What help to achieve high success rate?
by: AMAR Talib AL-HAMDI, et al.
Published: (2021-05-01)

Intravenous Cavutilide for Pharmacological Conversion of Paroxysmal and Persistent Atrial Fibrillation in Patients with Heart Failure
by: Maria M. Beliaeva, et al.
Published: (2023-12-01)

How to Manage Atrial Fibrillation in the Emergency Department: a Critical Appraisal
by: Rafael Thiesen Magliari, et al.
Published: (2020-06-01)

Insights from clinical trials: New evidence supports surgical interventions over drug therapies for atrial fibrillation
by: Akshat D. Modi, et al.
Published: (2024-06-01)

Early Risk of Stroke in Patients Undergoing Acute Versus Elective Cardioversion for Atrial Fibrillation
by: Tomas Forslund, et al.
Published: (2021-08-01)

Transvenous, intracardial cardioversion for the treatment of postoperative atrial fibrillation
by: Fitzgerald Robert, et al.
Published: (2008-01-01)

Outcomes of hospitalizations with atrial fibrillation-flutter on a weekday versus weekend: an analysis from a 2014 nationwide inpatient sample
by: Dinesh C. Voruganti, et al.
Published: (2019-01-01)

Frequency Analysis of Atrial Fibrillation From the Surface Electrocardiogram
by: Daniela Husser, et al.
Published: (2004-07-01)

Rivaroxaban in atrial fibrillation cardioversion: an update
by: Lavalle C, et al.
Published: (2019-05-01)

US Antiarrhythmic Drug Treatment for Patients With Atrial Fibrillation: An Insurance Claims–Based Report
by: Jonathan G. Tardos, et al.
Published: (2021-03-01)

2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation
by: Chern-En Chiang, et al.
Published: (2016-11-01)

Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT‐AF
by: Jeffrey B. Washam, et al.
Published: (2018-09-01)

CURRENT PRINCIPLES AND TRENDS OF ATRIAL FIBRILLATION PHARMACOTHERAPY
by: Yu. A. Bunin
Published: (2016-01-01)

The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation
by: Thomas D, et al.
Published: (2011-03-01)

Current clinical practice guidelines in atrial fibrillation: a review
by: osé Kelvin Galvez-Olortegui, et al.
Published: (2016-03-01)

Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account
by: Fabiana Lucà, et al.
Published: (2021-07-01)

Real‐life experience with non‐vitamin K antagonist oral anticoagulants versus warfarin in patients undergoing elective cardioversion of atrial fibrillation
by: Saga Itäinen‐Strömberg, et al.
Published: (2020-09-01)

Impact of a Multidisciplinary Treatment Pathway for Atrial Fibrillation in the Emergency Department on Hospital Admissions and Length of Stay: Results of a Multi‐Center Study
by: Leon M. Ptaszek, et al.
Published: (2019-09-01)

Current Status of Internal Cardioversion in Atrial Fibrillation.
by: Andreas Plewan, et al.
Published: (2002-04-01)

Nonadherence to guideline-directed anticoagulations in atrial fibrillation in Iraq
by: Ameen M Mohammad, et al.
Published: (2021-01-01)

Clinical presentation, management, and outcomes in the Indian Heart Rhythm Society-Atrial Fibrillation (IHRS-AF) registry
by: A. Vora, et al.
Published: (2017-01-01)

PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE TREATMENT OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION IN EVERY DAY CLINICAL PRACTICE
by: I. V. Graifer, et al.
Published: (2016-01-01)

The Experimental TASK-1 Potassium Channel Inhibitor A293 Can Be Employed for Rhythm Control of Persistent Atrial Fibrillation in a Translational Large Animal Model
by: Felix Wiedmann, et al.
Published: (2021-01-01)

Analysis of clinical risk factors of failed electrical cardioversion in patients with persistent atrial fibrillation or atrial flutter
by: Ki-Hun Kim, et al.
Published: (2023-08-01)

Impact of Emergency Department Management of Atrial Fibrillation on Hospital Charges
by: Sacchetti, Alfred, et al.
Published: (2013-02-01)

Atrial Fibrillation after Cardiac Surgery: Where are we now?
by: Dimpi Patel, et al.
Published: (2008-11-01)

Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion
by: Giuseppe Coppola, et al.
Published: (2019-09-01)

2016 ESC GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION DEVELOPEDIN COLLABORATION WITH EACTS
by: Paulus Kirchhof, et al.
Published: (2017-08-01)